4//SEC Filing
Schlorff Eric 4
Accession 0000899243-22-034685
CIK 0001831868other
Filed
Oct 31, 8:00 PM ET
Accepted
Nov 1, 4:15 PM ET
Size
11.5 KB
Accession
0000899243-22-034685
Insider Transaction Report
Form 4
Schlorff Eric
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-10-28+83,985→ 83,985 totalExercise: $0.53Exp: 2030-02-20→ Common Stock (83,985 underlying) - Award
Common Stock, par value $0.0001 per share
2022-10-28+198,530→ 198,530 total - Award
Stock Option (Right to Buy)
2022-10-28+17,986→ 17,986 totalExercise: $10.00Exp: 2029-03-01→ Common Stock (17,986 underlying)
Footnotes (4)
- [F1]Represents the Issuer's common stock subject to restricted stock units (RSUs). Pursuant to the Agreement and Plan of Merger by and among the Issuer, LMF Merger Sub, Inc., and SeaStar Medical Inc. ("SeaStar Medical"), dated April 21, 2022 (as amended, the "Merger Agreement"), at the Effective Time (as defined in the Merger Agreement), each award of RSUs based on SeaStar Medical common stock that was outstanding immediately prior to the Effective Time was converted into the right to receive RSUs based on the common stock of the Issuer with the same terms and conditions as were applicable to such SeaStar Medical RSU awards immediately prior to the Effective Time, subject to the applicable exchange ratio. Fifty percent (50%) of the shares subject to RSUs reported herein will vest on the first anniversary of the Effective Time, thereafter the remaining will vest on a monthly basis over a 24-month period.
- [F2]Pursuant to the Merger Agreement, at the Effective Time, each outstanding option to purchase shares of SeaStar Medical common stock was assumed and converted into an option to purchase shares of common stock of the Issuer with the same terms and conditions as were applicable to such option immediately prior to the Effective Time, subject to the applicable exchange ratio.
- [F3]The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from March 1, 2019 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from March 1, 2020.
- [F4]The option vests with respect to (i) twenty-five percent (25%) of the shares upon completion of one (1) year of service measured from February 20, 2020 and (ii) the balance of the shares subject to the option in a series of thirty-six (36) successive equal monthly installments upon completion of each additional month of service over the thirty-six (36)-month period measured from February 20, 2021.
Documents
Issuer
SeaStar Medical Holding Corp
CIK 0001831868
Entity typeother
Related Parties
1- filerCIK 0001949738
Filing Metadata
- Form type
- 4
- Filed
- Oct 31, 8:00 PM ET
- Accepted
- Nov 1, 4:15 PM ET
- Size
- 11.5 KB